Fair Value of Financial Instruments - Rollforward of Level 3 Inputs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Feb. 28, 2023
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Other income (expense), net	$ 1	$ 0	$ (1)
Common Class B
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Cash	$ 2
Shares issued (in shares)	37,179
Common Class B | Subsequent Event
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Cash				$ 2
Shares issued (in shares)				38,908
Warrants | Preferred Stock Warrants
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Beginning balance	$ 0	11
Fair value at issuance		0
Fair value on the acquisition date		0
Change in fair value and other adjustments	0	38
Settlement	0	(43)
Conversion of preferred stock warrants into common stock warrants upon initial public offering		(6)
Ending balance	0	0	11
Other income (expense), net			8
Warrants | Common Stock Warrant Liability
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Beginning balance	181	0
Fair value at issuance		125
Fair value on the acquisition date		0
Change in fair value and other adjustments	(95)	59
Settlement	(18)	(9)
Conversion of preferred stock warrants into common stock warrants upon initial public offering		6
Ending balance	68	181	0
Derivative Liability
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Beginning balance	0	37
Fair value at issuance		0
Fair value on the acquisition date		0
Change in fair value and other adjustments	0	103
Settlement	0	(140)
Conversion of preferred stock warrants into common stock warrants upon initial public offering		0
Ending balance	0	0	37
Contingent Consideration Liability (2)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Beginning balance	5	0
Fair value at issuance		0
Fair value on the acquisition date		2
Change in fair value and other adjustments	3	3
Settlement	(4)	0
Conversion of preferred stock warrants into common stock warrants upon initial public offering		0
Ending balance	$ 4	$ 5	$ 0